A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients
Ivermectin (IVM) and moxidectin (MOX) are used extensively as parasiticides in veterinary medicine. Based on in vitro data, IVM has recently been proposed for the prevention and treatment of COVID-19 infection, a condition for which obesity is a major risk factor. In patients, IVM dosage is based on...
Saved in:
Main Authors: | Alain Bousquet-Mélou (Author), Anne Lespine (Author), Jean-François Sutra (Author), Isabelle Bargues (Author), Pierre-Louis Toutain (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relative neurotoxicity of ivermectin and moxidectin in Mdr1ab (-/-) mice and effects on mammalian GABA(A) channel activity.
by: Cécile Ménez, et al.
Published: (2012) -
Population Pharmacokinetic Study of Cefazolin Used Prophylactically in Canine Surgery for Susceptibility Testing Breakpoint Determination
by: Petra Cagnardi, et al.
Published: (2018) -
Biased computation of probability of target attainment for antimicrobial drugs
by: Pierre‐Louis Toutain, et al.
Published: (2023) -
Time-Kill Analysis of Canine Skin Pathogens: A Comparison of Pradofloxacin and Marbofloxacin
by: Stefano Azzariti, et al.
Published: (2023) -
Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model.
by: Charlotte Bernigaud, et al.
Published: (2016)